<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02737280</url>
  </required_header>
  <id_info>
    <org_study_id>EETTMK2015</org_study_id>
    <nct_id>NCT02737280</nct_id>
  </id_info>
  <brief_title>High Flow Nasal Cannula Use in Infants With Bronchiolitis</brief_title>
  <official_title>High Flow Humified Nasal Cannula Oxygen Therapy in Infants Younger Than 6 Months of Age With Viral Bronchiolitis Compared to Usual Oxygen Therapy : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants with viral bronchiolitis are currently treated with oxygen therapy if oxygen
      saturation is low. In earlier observational clinical studies, the use of high flow nasal
      cannulae therapy in infants with bronchiolitis has been associated with a decreased rate of
      intubation and intensive care. This study is a randomized controlled trial in two pediatric
      university hospitals in Finland comparing high flow nasal cannulae therapy to usual oxygen
      therapy in infants with bronchiolitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infants with viral bronchiolitis are currently treated with oxygen therapy if oxygen
      saturation is low. In earlier observational clinical studies, the use of high flow nasal
      cannulae therapy in infants with bronchiolitis has been associated with a decreased rate of
      intubation and intensive care. This study is a randomized controlled trial in five pediatric
      university hospitals in Finland comparing high flow nasal cannulae therapy to usual oxygen
      therapy in infants with bronchiolitis.

      The investigators will recruit 160 infants who require oxygen therapy (oxygen saturation
      &lt;92%) during hospitalization due to a viral bronchiolitis. The participants are randomized to
      receive oxygen therapy either with high flow or ordinary nasal cannula.The infants are
      closely observed by study physicians for clinical parameters. The primary end point is
      treatment failure (need for change of respiratory support method). Secondary endpoints are
      respiratory rate (RR) and oxygen saturation (%) at specific measuring points, time from
      randomisation to end of oxygen therapy and time from randomisation to discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with treatment failure</measure>
    <time_frame>720 hours</time_frame>
    <description>Treatment failure = need for change of respiratory support method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate measured by the study physician/nurse</measure>
    <time_frame>At 30 min, 60 min, 90 min, 4 hours, 8 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation (%)</measure>
    <time_frame>At 30 min, 60 min, 90 min, 4 hours, 8 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from randomisation to end of oxygen therapy</measure>
    <time_frame>At 30 min, 60 min, 90 min, 4 hours, 8 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from hospital admission to discharge (hours)</measure>
    <time_frame>720 hours</time_frame>
    <description>The date and time for admission and discharge will be registered for each participant and time from hospital admission to discharge is then calculated in hours and compared between the study groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants needing admission to intensive care unit (ICU)</measure>
    <time_frame>720 hours</time_frame>
    <description>The number of participants needing admission to intensive care unit (ICU) will be registered in both treatment groups and that number divided by the total number of participants in the groups (percentages) are then compared between the study groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>Usual oxygen therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxygen therapy with normal nasal cannula (for example MedKit Finland) 0-2 l/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow oxygen therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High flow nasal cannula oxygen therapy with Airvo (TM, Fisher &amp; Paykel Healthcare) device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Airvo (TM, Fisher &amp; Paykel Healthcare) - High flow oxygen therapy</intervention_name>
    <description>High flow nasal cannula therapy with Airvo (TM, Fisher &amp; Paykel Healthcare) device</description>
    <arm_group_label>High flow oxygen therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MedKit Finland - Usual oxygen therapy</intervention_name>
    <description>Oxygen therapy with normal nasal cannula (for example MedKit Finland) 0-2 l/min</description>
    <arm_group_label>Usual oxygen therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission to pediatric ward due to a presumed viral bronchiolitis

          -  Need of oxygen therapy (oxygen saturation &lt; 92%)

        Exclusion Criteria:

          -  Pertussis

          -  Needs intubation or CPAP on admission

          -  Severe congenital heart defect

          -  Down's syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marjo Renko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oulu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marjo Renko, MD, PhD</last_name>
    <phone>+358-8-3155132</phone>
    <email>marjo.renko@oulu.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Terhi Tapiainen, MD, PhD</last_name>
    <phone>+358-8-3155185</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Central Hospital Jyväskylä</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Aaltonen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu Unversity Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjo Renko, MD, PhD</last_name>
      <email>marjo.renko@oulu.fi</email>
    </contact>
    <contact_backup>
      <last_name>Terhi Tapiainen, MD, PhD</last_name>
      <email>terhi.tapiainen@oulu.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Marjo Renko, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Terhi Tapiainen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsi Nuolivirta, docent</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Korppi, MD, PhD</last_name>
      <email>matti.korppi@uta.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2016</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Marjo Renko</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>infant</keyword>
  <keyword>high flow nasal cannulae</keyword>
  <keyword>oxygen therapy</keyword>
  <keyword>bronchiolitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

